Patent Assignment
Reel/Frame 067489/0445
Assignment of Assignor's Interest
Recorded: 2024-05-22
Pages: 10
Assignor
VIELA BIO, INC.
Executed: 2021-05-31
Assignee
HORIZON THERAPEUTICS IRELAND DAC
CONNAUGHT HOUSE, 1ST FLOOR, 1 BURLINGTON ROAD, DUBLIN, D04 C5Y6, IRELAND
Covered Properties
(2)
Antibodies to Feline Mcdonough Sarcoma (Fms)-Like Tyrosine Kinase 3 Receptor Ligand (FLT3L) and Uses Thereof for Treating Autoimmune and Inflammatory Diseases
Antibodies to Feline Mcdonough Sarcoma (Fms)-Like Tyrosine Kinase 3 Receptor Ligand (FLT3L) and Uses Thereof for Treating Autoimmune and Inflammatory Diseases
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest
Mar 7, 2022
From: MEDIMMUNE, LLC
To: VIELA BIO, INC.
Reel/Frame 059183/0481 →
Assignment of Assignor's Interest
Mar 7, 2022
From: HANSEN, ANNA; XIAO, XIAODONG; PAVLIK, PETER; CHEN, YAN
To: VIELA BIO, INC.
Reel/Frame 059183/0491 →
Assignment of Assignor's Interest
Oct 19, 2022
From: HANSEN, ANNA; XIAO, XIAODONG; PAVLIK, PETER; CHEN, YAN
To: VIELA BIO, INC.
Reel/Frame 061468/0294 →
Confirmatory Assignment
Oct 19, 2022
From: ETTINGER, CATHERINE RACHEL
To: VIELA BIO, INC.
Reel/Frame 061710/0244 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →